Medication info
Twinx Tablet 80/5 mg

Twinx Tablet 80/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Youngpung Pharmaceutical Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
30 tablets/box [(10 tablets/Alu-Alu * 3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201706788 · Approved 2017.08.23 · Insurance code 661904820

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Youngpung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medication helps effectively lower blood pressure when patients with essential hypertension do not have sufficient control with amlodipine or telmisartan monotherapy. It contributes to stable blood pressure management and reduces the risk of cardiovascular complications. The drug is effective in controlling blood pressure by dilating blood vessels and blocking the actions of substances that raise blood pressure. It plays a crucial role in maintaining the patient's blood pressure at a stable level to protect their health. Therefore, the combination therapy of amlodipine and telmisartan improves hypertension management.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Precautions

This medication may pose serious risks to the fetus, especially in the second and third trimesters, therefore pregnant women or women who may become pregnant should not take this medication. The drug is contraindicated in patients with certain conditions, such as those with severe impairment of heart or liver function, hypotensive patients, those with specific heart valve diseases, and patients with severely reduced diabetes or kidney function. Caution is required when administering this medication to patients with primary aldosteronism, liver disease, gastrointestinal diseases, renal artery hypertension, etc., and special care is needed for the elderly. The most common side effects reported while taking this medication are dizziness and peripheral edema. The use of this medication during pregnancy may lead to severe issues such as reduced renal function in the fetus, oligohydramnios, and delayed skull formation, so it should be discontinued immediately upon confirmation of pregnancy. It is also safe for breastfeeding women not to take this medication. In patients with impaired kidney function, this medication can cause elevated potassium levels in the blood, so regular blood tests are necessary. Be cautious of drug interactions when used with other medications, especially with digoxin, lithium, warfarin, and non-steroidal anti-inflammatory drugs. This drug may cause dizziness or drowsiness while driving or operating machinery, so caution is needed. In cases of overdose, symptoms such as hypotension, cardiac rhythm abnormalities, and dizziness may occur; medical attention should be sought immediately, and appropriate treatment is necessary. The safety and efficacy of this medication have not been established for use in children, and its usage is not recommended.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • dysgeusia
  • tremors
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, it is important to maintain a room temperature, specifically between 1 to 30 degrees Celsius, during storage to preserve the drug's effectiveness for a longer duration.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu * 3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.